Skip to content
LexBuild

21 CFR § 1307.14 - Delivery of controlled substances to designated locations of emergency medical services agencies.

---
identifier: "/us/cfr/t21/s1307.14"
source: "ecfr"
legal_status: "authoritative_unofficial"
title: "21 CFR § 1307.14 - Delivery of controlled substances to designated locations of emergency medical services agencies."
title_number: 21
title_name: "Food and Drugs"
section_number: "1307.14"
section_name: "Delivery of controlled substances to designated locations of emergency medical services agencies."
chapter_name: "DRUG ENFORCEMENT ADMINISTRATION, DEPARTMENT OF JUSTICE"
part_number: "1307"
part_name: "MISCELLANEOUS"
positive_law: false
currency: "2026-04-05"
last_updated: "2026-04-05"
format_version: "1.1.0"
generator: "[email protected]"
authority: "21 U.S.C. 821, 822(d), 823(k), 871(b), unless otherwise noted."
regulatory_source: "36 FR 7801, Apr. 24, 1971, unless otherwise noted. Redesignated at 38 FR 26609, Sept. 24, 1973."
cfr_part: "1307"
---

# 1307.14 Delivery of controlled substances to designated locations of emergency medical services agencies.

(a) Notwithstanding the definition of registered location in § 1300.06 of this chapter, a registered emergency medical services agency may receive controlled substances from a hospital for purposes of restocking an emergency medical services vehicle following an emergency response, and without being subject to the requirements of § 1305.03 of this chapter, provided all of the following criteria are met:

(1) The registered or designated location of the agency operating the vehicle maintains the record of such receipt in accordance with § 1304.27(b) of this chapter;

(2) The hospital maintains a record of such delivery to the agency in accordance with § 1304.22(c) of this chapter; and

(3) If the vehicle is primarily situated at a designated location of an emergency medical services agency, such location notifies the registered location of the agency within 72 hours of the vehicle receiving the controlled substances.

[91 FR 5242, Feb. 5, 2026]